Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/31/2018
Entire Document
 


By signing this letter agreement, the parties hereto have confirmed their agreement with the foregoing.

 

Sincerely yours,
NALPROPION PHARMACEUTICALS, INC.
By:  

/s/ John A. Sedor

  Name:   John A. Sedor
  Title:   Chief Executive Officer

[Signature Page to APA Amendment]